The Ecstasy and Agony of Assay Interference Compounds-Reference-Cited by-同舟云学术

The Ecstasy and Agony of Assay Interference Compounds

Published:2017-02-28 Issue:4 Volume:8 Page:379-382
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Aldrich Courtney¹^ORCID,Bertozzi Carolyn²^ORCID,Georg Gunda I.³^ORCID,Kiessling Laura⁴^ORCID,Lindsley Craig⁵^ORCID,Liotta Dennis⁶^ORCID,Merz Kenneth M.⁷^ORCID,Schepartz Alanna⁸^ORCID,Wang Shaomeng³^ORCID

Affiliation:

1. ACS Infectious Diseases

2. ACS Central Science

3. Journal of Medicinal Chemistry

4. ACS Chemical Biology

5. ACS Chemical Neuroscience

6. ACS Medicinal Chemistry Letters

7. Journal of Chemical Information and Modeling

8. Biochemistry

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00056

Reference42 articles.

1. Chemistry: Chemical con artists foil drug discovery

2. A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

3. Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation

4. Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors

5. Structure-based discovery of an immunomodulatory inhibitor of TLR1–TLR2 heterodimerization from a natural product-like database

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A strategy for inhibitors screening of xanthine oxidase based on colorimetric sensor combined with affinity chromatography technology;Biosensors and Bioelectronics;2024-10

2. Discovery of highly potent small molecule pan-coronavirus fusion inhibitors;2023-01-18

3. A Strategy for Inhibitors Screening of Xanthine Oxidase Based on Colorimetric Sensor Combined with Affinity Chromatography Technology;2023

4. A Strategy for Inhibitors Screening of Xanthine Oxidase Based on Colorimetric Sensor Combined with Affinity Chromatography Technology;2023

5. Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease;Pharmaceuticals;2022-12-23